Olipass Corporation (244460)

Currency in KRW
1,651
0(0.00%)
Closed·
244460 Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week Low
244460 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,5682,080
52 wk Range
1,5689,250
Key Statistics
Bid/Ask
1,651.00 / 1,657.00
Prev. Close
1,651
Open
1,650
Day's Range
1,568-2,080
52 wk Range
1,568-9,250
Volume
-
Average Volume (3m)
420.31K
1-Year Change
-74.4%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
244460 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Olipass Corporation Company Profile

OLIPASS Corporation, a biotech company, focuses on developing therapeutic products in South Korea. The company develops its products using its novel PNA based technologies. Its products pipeline includes SCN9A, a product candidate that is in Phase II clinical trials for the treatment of pain. The company also develops PCSK9 for the treatment of hyper cholesterolemia; VEGF for the treatment of AMD/DR; HIF-1a for chemo/radio-sensitizer treatment; Dystrophin for the treatment of duchenne muscular disease; and PTP1B for the treatment of type II diabetes. It is also involved in the development of CTLA4 immuno-oncology, PD1 immuno-oncology, and NOX4 fibrosis. In addition, the company engages in the collaborative research and development with OliPass Cosmeceuticals for life style management solutions, as well as Target X1 and Target X2. OLIPASS Corporation was founded in 2006 and is headquartered in Yongin-si, South Korea.

Compare 244460 to Peers and Sector

Metrics to compare
244460
Peers
Sector
Relationship
P/E Ratio
0.0x−4.4x−0.5x
PEG Ratio
0.00−0.090.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x19.7x3.3x
Upside (Analyst Target)
0.0%31.1%43.3%
Fair Value Upside
Unlock0.0%6.9%Unlock

Earnings

Latest Release
Nov 14, 2023
EPS / Forecast
-864.23 / --
Revenue / Forecast
1.81B / --
EPS Revisions
Last 90 days

244460 Income Statement

FAQ

What Stock Exchange Does Olipass Trade On?

Olipass is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Olipass?

The stock symbol for Olipass is "244460."

What Is the Olipass Market Cap?

As of today, Olipass market cap is 9.57B.

What Is Olipass's Earnings Per Share (TTM)?

The Olipass EPS (TTM) is -5,043.35.

From a Technical Analysis Perspective, Is 244460 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Olipass Stock Split?

Olipass has split 2 times.

How Many Employees Does Olipass Have?

Olipass has 78 employees.

What is the current trading status of Olipass (244460)?

As of 11 Aug 2025, Olipass (244460) is trading at a price of 1,651.00, with a previous close of 1,651.00. The stock has fluctuated within a day range of 1,568.00 to 2,080.00, while its 52-week range spans from 1,568.00 to 9,250.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.